Latest Capital Deployment News

Bellavista Resources has successfully raised A$35 million through a two-tranche placement to fund its strategic acquisition and exploration plans in Canada and Australia.

Cluey Ltd has terminated its planned acquisition of Education Futures Group, the parent of Art of Smart, citing unmet conditions. The company remains focused on expanding its blended learning offerings and exploring new acquisition opportunities.

Magnum Mining and Exploration has completed its acquisition of the Wet Mountain Rare Earth Element Project in Colorado, marking a significant step in its U.S. critical minerals strategy. The project boasts historic surface assays up to 7.99% Total Rare Earth Elements, with exploration plans underway.

Bulletin Resources is gearing up for a new drilling campaign at its Lake Rebecca Gold Project while strengthening its financial footing through asset sales and investments.

Pathkey.AI has completed a strategic review, bolstered its leadership team, and secured $3.5 million in funding to accelerate growth and broaden its AI platform's applications beyond clinical trials.

G50 Corp has initiated core drilling at its Golconda Project amid a sharp rise in gallium, gold, and silver prices, while preparing to drill at White Caps. The company’s upgrade to OTCQX aims to boost U.S. investor access, complemented by recent board changes.

Clarity Pharmaceuticals reports robust progress in prostate cancer and neuroendocrine tumour trials alongside a strong cash position of $226.2 million, underpinning its path towards commercialisation.

Lord Resources has reported final assay results from its maiden drilling at the Ilgarari Copper Project, revealing significant high-grade copper extensions and refining its geological model.

Tolu Minerals Limited reports steady progress at its Tolukuma Gold Mine, advancing a major mine expansion project targeting 500 tonnes per day production by the first quarter of 2027. Key infrastructure developments, drilling expansion, and processing plant refurbishments underpin the company’s growth strategy.

Alexium International Group has acquired Microtek Laboratories’ microencapsulation business, marking a strategic pivot to manufacturing-led growth and raising $4.6 million to fund expansion. Despite a slight sales dip, the company is poised for a stronger 2026 with new product lines and military trials underway.

Opthea Limited has streamlined its operations with a NASDAQ delisting and completed a strategic review, positioning itself to advance the OPT-302 treatment for LAM with a robust cash position.

The Calmer Co. International Limited has reported a second consecutive quarter of revenue exceeding $2 million, driven by strong U.S. growth and record monthly sales in December. The company’s strategic focus on wholesale and B2B extract channels underpins its confidence in reaching breakeven this fiscal year.